Investing

10x Genomics : TXG

TXG

Stock Data

$15.46

$1.08 (6.53%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

HEALTH INFORMATION SERVICES

10x Genomics Inc is a pioneering life science technology firm based in Pleasanton, California, specializing in developing instruments, consumables, and software for analyzing biological systems. Its innovative product lineup includes the Chromium and Visium platforms, offering solutions for single cell gene expression, immune profiling, and spatial analysis of biological samples. These tools are crucial for researchers in academia, government, and the biopharmaceutical industry, aiming to unlock complex biological insights at the cellular and molecular levels.

All 10x Genomics Articles

5 Articles

Omor Ibne Ehsan | Aug 21, 2025 at 10:26 AM EDT

2 Growth Stocks Cathie Wood Is Buying Non-Stop

Cathie Wood is most known for her bold, tech-first investing. She was an outlier during the 2021 boom as her…

Joey Frenette | Feb 2, 2025 at 7:40 PM EST

Cathie Wood’s Top Biotech Plays for February

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket…

Chris Lange | Aug 18, 2022 at 11:15 AM EDT

Bear Market Strikes Back: Analysts Upgrade or Downgrade Bed Bath & Beyond, Verizon and More

Thursday's additional top analyst upgrades and downgrades were on Analog Devices, Bed Bath & Beyond, Hasbro, Krispy Kreme, 10X Genomics,…

Chris Lange | Jul 15, 2022 at 11:05 AM EDT

More Problems More Spending: Analysts Upgrade or Downgrade CSX, Qualcomm and More

Friday's additional top analyst upgrades and downgrades included Allogene Therapeutics, CSX, Norfolk Southern, Qualcomm, Toyota and Yelp.

Paul Ausick | Feb 17, 2022 at 8:14 AM EST

Thursday’s 10 Premarket Winners and Losers Include Cisco, Palantir and Nvidia

Stocks were trading lower in Thursday's premarket. Here is a look at the leaders and the laggards.